Deboxamet
- Level
- Commodity
- Parent
- 51171900
- Below
- 0
- Links · KBLI
- 9
Definition
UNSPSC 51171934This classification denotes an anti-ulcer agent with the molecular formula C12H14N2O3, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier QJH0XA6AW9, chemically known as 1h-indole-3-acetamide, n-hydroxy-5-methoxy-2-methyl- but generally known as deboxamet, which bears US NIH Compound Identifier 36660. European Medicines Agency schedules Deboxamet in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB06927MIG. The term DEBOXAMET is an International Non-Proprietary Name or INN (see WHO INN reference publication, Volume 35, No. 5 1981, List 21). DEBOXAMET is scheduled in the U.S. International Trade Commission's Harmonized Tariff System (HTS) Pharmaceutical Appendix. Most nations schedule deboxamet under HS 29339990 and SITC 51577. As of Q4 2014, DEBOXAMET remains the US FDA Preferred Term for this commodity. Deboxamet bears US NLM identifiers UMLS ID C0636219 and NCI Concept Code C76483. SMILES: CC1=C(C2=C(N1)C=CC(=C2)OC)CC(=O)NO.
Same parent
Under 51171900 · 73Activities that produce or sell this
KBLI · 9Inherited from family 51170000.
Warning
The links were generated with a large language model (Gemini 3.5 Flash), matching UNSPSC at the family level to KBLI at the kelompok level. Some of them maybe are wrong, so check any link you intend to rely on.